Hoseini SM, Moghaddam AA, Ghelichpour M, Pagheh E, Haghpanah A, Gharavi B
Important clinical note: Prescribers should counsel patients that compounded preparations are not FDA-approved, that quality can vary between pharmacies, and that the evidence base for specific compounded formulations is more limited than for FDA-approved products
PX-12 inhibits the growth of hepatocelluar carcinoma by inducing S-phase arrest, ROS-dependent apoptosis and enhances 5-FU cytotoxicity
These wastes are then excreted in the urine
gamma-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation
All research citations on this page relate to pre-clinical studies and peer-reviewed pharmacological research and do not constitute a claim of safety or therapeutic efficacy